Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.

Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.

midregional proadrenomedullin (MR-proADM) is a prognostic biomarker in patients with community-acquired pneumonia (CAP). We sought to confirm whether MR-proADM added to Pneumonia Severity Index (PSI) improves the potential prognostic value of PSI alone, and tested to what extent this combination cou...

Full description

Bibliographic Details
Main Authors: Susana Gordo-Remartínez, María Calderón-Moreno, Juan Fernández-Herranz, Ana Castuera-Gil, Mar Gallego-Alonso-Colmenares, Carolina Puertas-López, José A Nuevo-González, Domingo Sánchez-Sendín, Mercedes García-Gámiz, José A Sevillano-Fernández, Luis A Álvarez-Sala, Juan A Andueza-Lillo, José M de Miguel-Yanes
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4452655?pdf=render

Internet

http://europepmc.org/articles/PMC4452655?pdf=render

Similar Items